Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 6, 2019
Reporting Period: The filing discloses a corporate presentation current as of December 6, 2019, intended for use at industry conferences.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of a corporate presentation (Exhibit 99.1) and does not contain audited financial statements or specific financial data points within the body of the text.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document is a procedural disclosure under Regulation FD regarding the distribution of summary business information.
Guidance, Outlook, and Risks
- Management Commentary: The Company provides summary business information via a "Corporate Presentation" attached as Exhibit 99.1.
- Forward-Looking Statements: The Company explicitly disclaims any obligation to correct or update the material in the Corporate Presentation in the future.
- Legal Status of Information: The information in the attached presentation is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for specific business metrics and strategic updates, as the 8-K text itself contains no data.
- Verify the date of the presentation (December 6, 2019) to ensure the information is not outdated.
- Note the disclaimer that the Company is under no obligation to update the presentation, requiring investors to seek newer filings for current status.